Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts.

Mer AS, Ba-Alawi W, Smirnov P, Wang YX, Brew B, Ortmann J, Tsao MS, Cescon DW, Goldenberg A, Haibe-Kains B.

Cancer Res. 2019 Sep 1;79(17):4539-4550. doi: 10.1158/0008-5472.CAN-19-0349. Epub 2019 May 29.

PMID:
31142512
2.

Expression levels of long non-coding RNAs are prognostic for AML outcome.

Mer AS, Lindberg J, Nilsson C, Klevebring D, Wang M, Grönberg H, Lehmann S, Rantalainen M.

J Hematol Oncol. 2018 Apr 7;11(1):52. doi: 10.1186/s13045-018-0596-2.

3.

Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.

Thu KL, Silvester J, Elliott MJ, Ba-Alawi W, Duncan MH, Elia AC, Mer AS, Smirnov P, Safikhani Z, Haibe-Kains B, Mak TW, Cescon DW.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1570-E1577. doi: 10.1073/pnas.1719577115. Epub 2018 Jan 29.

4.

Software for the Integration of Multiomics Experiments in Bioconductor.

Ramos M, Schiffer L, Re A, Azhar R, Basunia A, Rodriguez C, Chan T, Chapman P, Davis SR, Gomez-Cabrero D, Culhane AC, Haibe-Kains B, Hansen KD, Kodali H, Louis MS, Mer AS, Riester M, Morgan M, Carey V, Waldron L.

Cancer Res. 2017 Nov 1;77(21):e39-e42. doi: 10.1158/0008-5472.CAN-17-0344.

5.

Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.

El-Hachem N, Ba-Alawi W, Smith I, Mer AS, Haibe-Kains B.

Pharmacogenomics. 2017 Nov;18(16):1469-1472. doi: 10.2217/pgs-2017-0132. Epub 2017 Oct 23. No abstract available.

6.

Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.

Wang M, Lindberg J, Klevebring D, Nilsson C, Mer AS, Rantalainen M, Lehmann S, Grönberg H.

Leukemia. 2017 Oct;31(10):2029-2036. doi: 10.1038/leu.2017.48. Epub 2017 Feb 7.

7.

Study design requirements for RNA sequencing-based breast cancer diagnostics.

Mer AS, Klevebring D, Grönberg H, Rantalainen M.

Sci Rep. 2016 Feb 1;6:20200. doi: 10.1038/srep20200.

8.

mBISON: Finding miRNA target over-representation in gene lists from ChIP-sequencing data.

Gebhardt ML, Mer AS, Andrade-Navarro MA.

BMC Res Notes. 2015 Apr 16;8:157. doi: 10.1186/s13104-015-1118-8.

9.

A novel approach for protein subcellular location prediction using amino acid exposure.

Mer AS, Andrade-Navarro MA.

BMC Bioinformatics. 2013 Nov 28;14:342. doi: 10.1186/1471-2105-14-342.

10.

MicroRNAs modulate the dynamics of the NF-κB signaling pathway.

Vaz C, Mer AS, Bhattacharya A, Ramaswamy R.

PLoS One. 2011;6(11):e27774. doi: 10.1371/journal.pone.0027774. Epub 2011 Nov 17.

Supplemental Content

Support Center